Posted by Michael Wonder on 28 Feb 2016
Pharmaceutical policy reform - balancing affordability with incentives for innovation
25 February 2016 - Congressional investigations are examining the way in which drug companies set prices, and proposals for making drug pricing more transparent are pending in seven state legislatures.
For more details, go to: http://www.nejm.org/doi/full/10.1056/NEJMp1515068?query=TOC
